Literature DB >> 12150887

IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13.

Padraic G Fallon1, Helen E Jolin, Philippa Smith, Claire L Emson, Michael J Townsend, Rosie Fallon, Philip Smith, Andrew N J McKenzie.   

Abstract

Functional redundancy is highly prevalent among the Th2 interleukins (IL)-4, IL-5, IL-9, and IL-13. To define the critical functions of these cytokines, we have generated a novel panel of compound Th2 cytokine-deficient mice (from single to quadruple cytokine knockouts). We find that these Th2 cytokines are not essential for fetal survival even during allogeneic pregnancy. Using intestinal parasite infection and a pulmonary granuloma model, we demonstrate cryptic roles for IL-4, IL-5, IL-9, and IL-13 in these responses. Significantly, although IL-5, IL-9, and IL-13 add to the speed and magnitude of the response, a threshold is reached at which IL-4 alone can activate all Th2 effector functions. These mice reveal distinct spatial, temporal, and hierarchical cytokine requirements in immune function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12150887     DOI: 10.1016/s1074-7613(02)00332-1

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  118 in total

1.  Innately moving away from the Th1/Th2 paradigm in pregnancy.

Authors:  G Chaouat
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

2.  Systemically dispersed innate IL-13-expressing cells in type 2 immunity.

Authors:  April E Price; Hong-Erh Liang; Brandon M Sullivan; R Lee Reinhardt; Chris J Eisley; David J Erle; Richard M Locksley
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 3.  New insights into basophil biology: initiators, regulators, and effectors of type 2 inflammation.

Authors:  Mark C Siracusa; Michael R Comeau; David Artis
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

4.  Helminth regulation of host IL-4Ralpha/Stat6 signaling: mechanism underlying NOS-2 inhibition by Trichinella spiralis.

Authors:  Ka Bian; Meng Zhong; Yael Harari; Mildred Lai; Norman Weisbrodt; Ferid Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

Review 5.  Regulatory T cells in pregnancy.

Authors:  Ana Claudia Zenclussen
Journal:  Springer Semin Immunopathol       Date:  2006-07-13

6.  Social enrichment attenuates chemotherapy induced pro-inflammatory cytokine production and affective behavior via oxytocin signaling.

Authors:  William H Walker; O Hecmarie Meléndez-Fernández; Jordan L Pascoe; Ning Zhang; A Courtney DeVries
Journal:  Brain Behav Immun       Date:  2020-07-29       Impact factor: 7.217

7.  Depletion of major pathogenic cells in asthma by targeting CRTh2.

Authors:  Tao Huang; Meredith Hazen; Yonglei Shang; Meijuan Zhou; Xiumin Wu; Donghong Yan; Zhonghua Lin; Margaret Solon; Elizabeth Luis; Hai Ngu; Yongchang Shi; Arna Katewa; David F Choy; Nandhini Ramamoorthi; Erick R Castellanos; Mercedesz Balazs; Min Xu; Wyne P Lee; Marissa L Matsumoto; Jian Payandeh; Joseph R Arron; Jo-Anne Hongo; Jianyong Wang; Isidro Hötzel; Cary D Austin; Karin Reif
Journal:  JCI Insight       Date:  2016-05-19

8.  IL-33-dependent induction of allergic lung inflammation by FcγRIII signaling.

Authors:  Melissa Y Tjota; Jesse W Williams; Tiffany Lu; Bryan S Clay; Tiara Byrd; Cara L Hrusch; Donna C Decker; Claudia Alves de Araujo; Paul J Bryce; Anne I Sperling
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

9.  A central role for the mast cell in early phase vasculitis in the Brown Norway rat model of vasculitis: a histological study.

Authors:  Catherine S Vinen; David R Turner; David B G Oliveira
Journal:  Int J Exp Pathol       Date:  2004-06       Impact factor: 1.925

10.  IL-25 improves luminal innate immunity and barrier function during parenteral nutrition.

Authors:  Aaron F Heneghan; Joseph F Pierre; Ankush Gosain; Kenneth A Kudsk
Journal:  Ann Surg       Date:  2014-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.